Results 81 to 90 of about 562,100 (312)

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

RM-CSTV: An effective high-resolution method of non-line-of-sight millimeter-wave radar 3-D imaging

open access: yesNational Science Open
Non-line-of-sight (NLOS) imaging is a novel radar sensing technology that enables the reconstruction of hidden targets. However, it may suffer from synthetic aperture length reduction caused by ambient occlusion. In this study, a complex total variation (
Liu Xinyuan   +6 more
doaj   +1 more source

Photon Counting Integral Imaging Using Compound Photon Counting Model and Adaptive Parametric Maximum Likelihood Estimator

open access: yesIEEE Photonics Journal, 2017
In this paper, a statistical approach based on an adaptive parametric estimator is proposed for the three-dimensional (3-D) reconstruction of objects under photon-starved conditions.
Jiajia Qi   +3 more
doaj   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

open access: yesMolecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim   +3 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Experiments With Three-Dimensional Integral Imaging Under Low Light Levels

open access: yesIEEE Photonics Journal, 2012
We experimentally demonstrate the possibility of reconstructing 3-D scenes using integral imaging from very photon-starved scenes. It is shown that by using an iterative reconstruction algorithm, it is possible to reconstruct 3-D objects captured with an
Adrian Stern, Doron Aloni, Bahram Javidi
doaj   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Three-Dimensional Image Information Media. A Data Compression Method for 3-D Shapes with Network Spatial Partitioning Representation Model.

open access: yesThe Journal of the Institute of Image Information and Television Engineers, 1998
This paper describes a new data compression method for spatial partitioning representation which gives a higher data compression ratio than conventional methods. To obtain high data compression, we introduce the Network model, which performs fast geometric operations for spatial partitioning representation. The Network model represents a shape by using
Fujimura, Masao   +2 more
openaire   +2 more sources

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Spatial biology in cancer epigenetics

open access: yesMolecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

Home - About - Disclaimer - Privacy